Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

(2020) Hussin A. Rothan et al.   JOURNAL OF AUTOIMMUNITY

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures

(2020) Yixuan Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

(2020) Pan Luo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses

(2020) Furong Qi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review

(2020) Nicholas E. Ingraham et al.   EUROPEAN RESPIRATORY JOURNAL

Metformin and COVID‐19: A novel deal of an Old Drug

(2020) Amr Ahmed EL‐Arabey et al.   JOURNAL OF MEDICAL VIROLOGY

COVID-19: towards controlling of a pandemic

(2020) Juliet Bedford et al.   LANCET

Sex difference and smoking predisposition in patients with COVID-19

(2020) Hua Cai   Lancet Respiratory Medicine

Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study

(2020) Tak Kyu Oh et al.   Annals of Palliative Medicine

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

(2020) Sebastiano Bruno Solerte et al.   ACTA DIABETOLOGICA

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19

(2020) Zohreh Esam   DIABETES RESEARCH AND CLINICAL PRACTICE

Metformin in COVID-19: A possible role beyond diabetes

(2020) Swati Sharma et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 ( Covid ‐19)

(2020) Yue Zhou et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

(2020) Matteo Apicella et al.   Lancet Diabetes & Endocrinology

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

(2020) Sebastiano Bruno Solerte et al.   DIABETES CARE

Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus

(2019) Se Gwang Jang et al.   RHEUMATOLOGY

Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing

(2018) Francesco Prattichizzo et al.   AGEING RESEARCH REVIEWS

Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance

(2016) Amy R. Cameron et al.   CIRCULATION RESEARCH

Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis

(2016) Laura Negrotto et al.   JAMA Neurology

Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity

(2012) C. Seifarth et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Metformin in prostate cancer: two for the price of one

(2011) A. Clements et al.   ANNALS OF ONCOLOGY